Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes.
Harenberg
J
J
Department of Internal Medicine and Geriatrics, University Hospital, Mannheim, Germany. j-harenberg@t-online.de
D000925:Anticoagulants / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D016903:Drug Monitoring; D065427:Factor Xa Inhibitors; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight